TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19692216

Group type: EXPERIMENTAL
Intervention: VLC - very low carbohydrate diet (60% fat, 4% carbohydrate, n=30)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: VLF - very low fat diet (10% fat, n=30)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: HUF - high unsaturated fat diet (30% fat, n=30)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control group (no intervention, n=23)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Diet groups (VLC, VLF, HUF)
Number of subjects: 113
Study: 17665550

Group type: EXPERIMENTAL
Intervention: Individuals with known risk factors (4 risk factors)
Number of subjects: 2165

Group type: COMPARATOR
Intervention: Individuals without known risk factors (0 risk factors)
Number of subjects: 2165
Study: 18670743

Group type: EXPERIMENTAL
Intervention: Combination therapy (lentinan, RFA, and TACE)
Number of subjects: 78

Group type: COMPARATOR
Intervention: TACE only
Number of subjects: 78

Group type: COMPARATOR
Intervention: RFA only
Number of subjects: 78

Group type: COMPARATOR
Intervention: TACE/RFA
Number of subjects: 78
Study: 15591594

Group type: EXPERIMENTAL
Intervention: Stapled haemorrhoidectomy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Open diathermy haemorrhoidectomy
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 24
Study: 11312474

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 27

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 27
Study: 9161373

Group type: EXPERIMENTAL
Intervention: Gabapentin 400mg orally three times a day for 48 hours
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 8042734

Group type: EXPERIMENTAL
Intervention: Vital capacity breaths (4 or more)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vital capacity breaths (6)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vital capacity breaths (3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tidal breathing (3 min)
Number of subjects: 0
Study: 3581690

Group type: EXPERIMENTAL
Intervention: Carotid baroreceptor stimulation during head-out water immersion
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control condition (no immersion)
Number of subjects: 7
Study: 31504615

Group type: EXPERIMENTAL
Intervention: Tilapia skin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Silver sulfadiazine cream 1%
Number of subjects: 30
Study: 31848169

Group type: EXPERIMENTAL
Intervention: Belimumab administered 4 to 8 weeks after the first rituximab infusion for 52 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo administered 4 to 8 weeks after the first rituximab infusion for 52 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Belimumab
Number of subjects: 0
Study: 26040429

Group type: EXPERIMENTAL
Intervention: Pramlintide 6 mcg/unit insulin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pramlintide 9 mcg/unit insulin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pramlintide 12 mcg/unit insulin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24375222

Group type: EXPERIMENTAL
Intervention: 16 mL of 0.1285% ropivacaine
Number of subjects: 44
Study: 22246644

Group type: EXPERIMENTAL
Intervention: Disc prosthesis
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation
Number of subjects: 154

Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 154
Study: 19383515

Group type: EXPERIMENTAL
Intervention: Functional Electrical Therapy (FET)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 13
Study: 17341866

Group type: EXPERIMENTAL
Intervention: Topically applied indigo naturalis ointment
Number of subjects: 14

Group type: COMPARATOR
Intervention: Vehicle ointment (control)
Number of subjects: 14
Study: 16285544

Group type: EXPERIMENTAL
Intervention: NaF 1.23% added to 35% phosphoric acid
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: NaF 2% added to 35% phosphoric acid
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: NaF 3% added to 35% phosphoric acid
Number of subjects: 64

Group type: COMPARATOR
Intervention: NaF 0% (control) added to 35% phosphoric acid
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Group C (NaF 3%)
Number of subjects: 64
Study: 12505248

Group type: EXPERIMENTAL
Intervention: Active hormone replacement therapy (conjugated estrogens for women who had had a hysterectomy or conjugated estrogens with medroxyprogesterone for women with intact uteri)
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Active vitamins E and C
Number of subjects: 423

Group type: COMPARATOR
Intervention: Placebo for hormone replacement therapy
Number of subjects: 423

Group type: COMPARATOR
Intervention: Placebo for vitamins E and C
Number of subjects: 423
Study: 9869222

Group type: EXPERIMENTAL
Intervention: Surgery alone
Number of subjects: 114

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 114

Group type: COMPARATOR
Intervention: Postoperative irradiation
Number of subjects: 114

Group type: COMPARATOR
Intervention: Preoperative irradiation
Number of subjects: 114

Group type: COMPARATOR
Intervention: Combined treatment (surgery and radiotherapy)
Number of subjects: 114
Study: 7614811

Group type: COMPARATOR
Intervention: High sodium diet (200 mmol/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Low sodium diet (20 mmol/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Both diets
Number of subjects: 18
Study: 2692667

Group type: EXPERIMENTAL
Intervention: diatrizoate (ionic)
Number of subjects: 20

Group type: COMPARATOR
Intervention: iopromide (non-ionic)
Number of subjects: 20
Study: 773493

Group type: EXPERIMENTAL
Intervention: Bran tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-roughage diet (HRD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normacol plus an antispasmodic
Number of subjects: 0
Study: 30760163

Group type: EXPERIMENTAL
Intervention: Musical rhythmic skills
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Prosody production test
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Rhythm production abilities
Number of subjects: 23
Study: 30843238

Group type: EXPERIMENTAL
Intervention: Usual care with no suction (intervention arm)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual postoperative care including suction (control arm)
Number of subjects: 0
Study: 28916821

Group type: EXPERIMENTAL
Intervention: Donepezil (10 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26076690

Group type: EXPERIMENTAL
Intervention: Antecolic reconstruction of gastro/duodenojejunostomy
Number of subjects: 534

Group type: COMPARATOR
Intervention: Retrocolic reconstruction of gastro/duodenojejunostomy
Number of subjects: 534
Study: 23400823

Group type: EXPERIMENTAL
Intervention: Velaglucerase alfa
Number of subjects: 35

Group type: COMPARATOR
Intervention: Imiglucerase (60 U/kg every other week)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Imiglucerase
Number of subjects: 35
Study: 21054224

Group type: EXPERIMENTAL
Intervention: MIST plus EMD
Number of subjects: 30

Group type: COMPARATOR
Intervention: MIST alone
Number of subjects: 30
Study: 19476072

Group type: EXPERIMENTAL
Intervention: High-fidelity simulation (HFS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-fidelity simulation (LFS)
Number of subjects: 0
Study: 17439510

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg daily for 1 week, followed by 3 weeks of esomeprazole 40 mg daily
Number of subjects: 1121
Study: 15109761

Group type: EXPERIMENTAL
Intervention: Older women with limited dorsiflexion range of motion
Number of subjects: 15
Study: 11288947

Group type: EXPERIMENTAL
Intervention: Thromboprophylactic agents (specific agents not mentioned)
Number of subjects: 0

Group type: COMPARATOR
Intervention: New pharmacologic agent (specific agent not mentioned)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Venography (as a method for end-point measurement)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Noninvasive methods (as alternatives to venography)
Number of subjects: 0
Study: 10211050

Group type: EXPERIMENTAL
Intervention: Homogenized meal (HM)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Both meal types
Number of subjects: 8
Study: 7933255

Group type: EXPERIMENTAL
Intervention: Heart transplantation
Number of subjects: 68
Study: 3358924

Group type: EXPERIMENTAL
Intervention: Soya-bean protein (from soya-bean flour, soya-bean concentrate, or soya-bean isolate)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Meat protein (60 g)
Number of subjects: 7
Study: 30543723

Group type: EXPERIMENTAL
Intervention: pink-veneered customized zirconia abutments (test group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: nonveneered customized zirconia abutments (control group)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: both groups
Number of subjects: 20
Study: 28511917

Group type: EXPERIMENTAL
Intervention: Oral hypertonic saline (Ior)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Intravenous hypertonic saline (Iiv)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Oral hypertonic saline (IIor)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Intravenous hypertonic saline (IIiv)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Group I vs Group II
Number of subjects: 32
Study: 25908018

Group type: EXPERIMENTAL
Intervention: Inadequate health literacy
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Marginal health literacy
Number of subjects: 575
Study: 23650412

Group type: EXPERIMENTAL
Intervention: Chemotherapy with concurrent trastuzumab (arm C)
Number of subjects: 1802

Group type: EXPERIMENTAL
Intervention: Chemotherapy with sequential trastuzumab (arm B)
Number of subjects: 1802

Group type: COMPARATOR
Intervention: Chemotherapy alone (arm A)
Number of subjects: 1802
Study: 21767722

Group type: EXPERIMENTAL
Intervention: Qi-gong intervention
Number of subjects: 41
Study: 19454781

Group type: EXPERIMENTAL
Intervention: Biodex Stability System
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Tetrax System
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: EquiTest system for EMG recording
Number of subjects: 21
Study: 16461871

Group type: EXPERIMENTAL
Intervention: Telephone reminders for immunization and WCC visits
Number of subjects: 3006

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 3006
Study: 14967774

Group type: EXPERIMENTAL
Intervention: Galantamine hydrobromide
Number of subjects: 194
Study: 11789776

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 20

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 20
Study: 9670287

Group type: EXPERIMENTAL
Intervention: Mixed beam (neutron plus photon) irradiation
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Pure neutron irradiation
Number of subjects: 2
Study: 7800919

Group type: EXPERIMENTAL
Intervention: Stage I (30 min after the beginning of anaesthesia)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Stage II (30 min after adding 30 cm of dead space)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Stage III (30 min after replacing the previous VD with VD of 60 cm)
Number of subjects: 15
Study: 3353806

Group type: EXPERIMENTAL
Intervention: Soya-based formula with a mixture of sucrose and glucose polymers
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Soya-based formula with all carbohydrate as glucose polymers
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cows' milk formula
Number of subjects: 20
Study: 31456449

Group type: EXPERIMENTAL
Intervention: Citrulline Malate (8g)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Beetroot Juice (400mg nitrate)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 27
Study: 31198990

Group type: EXPERIMENTAL
Intervention: donor motivational interview (n = 544)
Number of subjects: 1177

Group type: COMPARATOR
Intervention: knowledge interview (n = 633)
Number of subjects: 1177

Group type: EXPERIMENTAL
Intervention: donor motivational interview (n = 544) among women
Number of subjects: 1177
Study: 28606215

Group type: EXPERIMENTAL
Intervention: Fatty fish (750 g/week)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Lean fish (750 g/week)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (normal eating habits, no fish)
Number of subjects: 68
Study: 26630617

Group type: EXPERIMENTAL
Intervention: 3% diquafosol ophthalmic solution
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0.1% hyaluronate ophthalmic solution
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 20
Study: 24072808

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 114
Study: 21977856

Group type: EXPERIMENTAL
Intervention: Liandou Qingmai Recipe (treatment group, n = 45)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard treatment (control group, n = 56)
Number of subjects: 101
Study: 20209464

Group type: EXPERIMENTAL
Intervention: 1 g GPLC
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 3 g GPLC
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 16549460

Group type: EXPERIMENTAL
Intervention: Cinnamon supplementation (1.5 g/d)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 15327724

Group type: EXPERIMENTAL
Intervention: Cognitive linguistic treatment
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Imitative treatment
Number of subjects: 3
Study: 12949287

Group type: EXPERIMENTAL
Intervention: Northstar Iontophoretic Drug Delivery System (IDDS) with lidocaine (100 mg of 10%) and epinephrine (1.05 mg of 1:10,000)
Number of subjects: 12
Study: 10950829

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 7.5% dextrose in healthy adults
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Insulin deficiency in young adults with IDDM
Number of subjects: 13
Study: 8981333

Group type: EXPERIMENTAL
Intervention: Oesclim 50
Number of subjects: 143

Group type: COMPARATOR
Intervention: Estraderm TTS 50
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 143
Study: 1550697

Group type: EXPERIMENTAL
Intervention: Enteric coated 500 mg 5-ASA tablets administered after standard meals
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Enteric coated 500 mg 5-ASA tablets administered 1 h before meals
Number of subjects: 12
Study: 3862607

Group type: EXPERIMENTAL
Intervention: 0.6 g oral N‐acetylcysteine/day for 60 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 12
Study: 2887401

Group type: EXPERIMENTAL
Intervention: Microdose intrauterine device releasing 2 micrograms of levonorgestrel per 24 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Copper IUDs (TCu 220C and Nova T)
Number of subjects: 0
Study: 31919558

Group type: EXPERIMENTAL
Intervention: Molidustat alone (fasted or fed)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Oral iron(II)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Calcium(II)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Molidustat with iron(II) intake 4 hours before
Number of subjects: 42
Study: 30307351

Group type: EXPERIMENTAL
Intervention: Environmental control behavioral intervention
Number of subjects: 222

Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 222
Study: 28590957

Group type: EXPERIMENTAL
Intervention: Cocaine (40 mg)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 66
Study: 25585595

Group type: EXPERIMENTAL
Intervention: Patient navigation intervention (telephone calls from a bilingual patient navigator 7 days and 1 day before the appointment)
Number of subjects: 4425

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 4425

Group type: EXPERIMENTAL
Intervention: Contact with patient or family member
Number of subjects: 4425

Group type: EXPERIMENTAL
Intervention: Leaving a message
Number of subjects: 4425

Group type: EXPERIMENTAL
Intervention: No contact
Number of subjects: 4425
Study: 23958375

Group type: EXPERIMENTAL
Intervention: Sunitinib (37.5 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of Care (SOC) chemotherapy
Number of subjects: 0
Study: 22308697

Group type: EXPERIMENTAL
Intervention: Berberine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Xuezhikang
Number of subjects: 60
Study: 19346501

Group type: EXPERIMENTAL
Intervention: Integrated Cognitive Stimulation and Training Program, 45 minutes a day, 2 days a week, for 6 weeks
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Integrated Cognitive Stimulation and Training Program
Number of subjects: 32
Study: 16442364

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Bare metal stents
Number of subjects: 226
Study: 15309626

Group type: EXPERIMENTAL
Intervention: High frequency oscillatory ventilation (HFOV)
Number of subjects: 487

Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (CMV)
Number of subjects: 487
Study: 11696046

Group type: EXPERIMENTAL
Intervention: Grass pollen immunotherapy (IT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo treatment (PL)
Number of subjects: 44
Study: 9385883

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy for acute myocardial infarction
Number of subjects: 40899

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy for acute myocardial infarction in patients with diabetes
Number of subjects: 40899

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy for acute myocardial infarction in patients without diabetes
Number of subjects: 40899
Study: 8201614

Group type: EXPERIMENTAL
Intervention: Orthodontic treatment
Number of subjects: 93

Group type: COMPARATOR
Intervention: Delayed control group (no immediate treatment)
Number of subjects: 93
Study: 3067303

Group type: EXPERIMENTAL
Intervention: labetalol (L)
Number of subjects: 42

Group type: COMPARATOR
Intervention: captopril (C)
Number of subjects: 42

Group type: COMPARATOR
Intervention: labetalol (L) and captopril (C)
Number of subjects: 42
Study: 30926396

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nasal dilator (placebo) treatment
Number of subjects: 30
Study: 28587582

Group type: EXPERIMENTAL
Intervention: Clopidogrel 600 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 25331850

Group type: EXPERIMENTAL
Intervention: Blood Pressure Reduction (BP change from baseline by -34/-21 mm Hg, 10th percentile)
Number of subjects: 19102

Group type: EXPERIMENTAL
Intervention: Blood Pressure Increase (BP change from baseline by +20/+10 mm Hg, 90th percentile)
Number of subjects: 19102
Study: 23218699

Group type: EXPERIMENTAL
Intervention: 2 mg intravitreal aflibercept (IAI 2Q4)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: 2 mg intravitreal aflibercept (IAI 2Q4 + PRN)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 189

Group type: COMPARATOR
Intervention: Sham + IAI PRN
Number of subjects: 189
Study: 21774626

Group type: EXPERIMENTAL
Intervention: Open patch test with 1% SLS
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 10× TAP
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: UVB irradiation with 0.75 MED
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Open patch test with 1% SLS + PT with 0.5% SLS (SLSPT)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 10× TAP + PT with 0.5% SLS (TAPPT)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: PT with distilled water (DISPT)
Number of subjects: 9

Group type: COMPARATOR
Intervention: PT with 0.5% SLS (PT)
Number of subjects: 9

Group type: COMPARATOR
Intervention: CONTROL (no treatment)
Number of subjects: 9
Study: 18215801

Group type: EXPERIMENTAL
Intervention: Less Invasive Stabilization System (LISS)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Classic double plates (DP)
Number of subjects: 84
Study: 16842918

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 3451

Group type: COMPARATOR
Intervention: Routine care (control)
Number of subjects: 3451
Study: 14586180

Group type: EXPERIMENTAL
Intervention: HDFst (constant dialysate K concentration)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: HDFK (decreased dialysate K concentration during session)
Number of subjects: 10
Study: 11742432

Group type: EXPERIMENTAL
Intervention: Clarithromycin 500 mg po bid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Azithromycin 1200 mg po weekly
Number of subjects: 0
Study: 9420127

Group type: EXPERIMENTAL
Intervention: Avoidance of cow's milk protein for 4 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maternal smoking during pregnancy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mother's atopic history
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Father's atopic history
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infant feeding method or number of older siblings
Number of subjects: 0
Study: 8237310

Group type: EXPERIMENTAL
Intervention: Beveled margins of cavity preparations
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Treatment of etched butt-joint cavities with NPG-GMA/ethanol, re-etching, and surface coating with low viscous resin
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both types of restorations
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Patients consuming alcoholic beverages
Number of subjects: 52
Study: 3566598

Group type: EXPERIMENTAL
Intervention: 0.5% timolol maleate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Timolol and Placebo (both groups)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nonpseudophakic eyes
Number of subjects: 60
Study: 30489424

Group type: EXPERIMENTAL
Intervention: TX-001HR (17β-estradiol and natural progesterone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27378556

Group type: EXPERIMENTAL
Intervention: Hyaluronan (HY) injections
Number of subjects: 22

Group type: COMPARATOR
Intervention: Saline solution (control) injection
Number of subjects: 22
Study: 25891749

Group type: EXPERIMENTAL
Intervention: Baseline urinary biomarker Coll2‐1NO2 (uColl2‐1NO2)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Follow-up urinary biomarker Coll2‐1NO2 at 2.5 years
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Change in urinary biomarker Coll2‐1NO2 over 2.5 years
Number of subjects: 254